PFE vs. SYK: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at PFE and SYK, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | PFE | SYK |
|---|---|---|
| Company Name | Pfizer Inc. | Stryker Corporation |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Pharmaceuticals | Health Care Equipment & Supplies |
| Market Capitalization | 145.01 billion USD | 138.01 billion USD |
| Exchange | NYSE | NYSE |
| Listing Date | June 1, 1972 | March 17, 1980 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of PFE and SYK by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | PFE | SYK |
|---|---|---|
| 5-Day Price Return | 2.75% | 2.03% |
| 13-Week Price Return | -0.32% | -5.16% |
| 26-Week Price Return | 9.58% | -6.53% |
| 52-Week Price Return | -6.21% | -6.73% |
| Month-to-Date Return | 1.66% | 1.68% |
| Year-to-Date Return | -5.54% | 0.60% |
| 10-Day Avg. Volume | 126.04M | 2.03M |
| 3-Month Avg. Volume | 58.66M | 1.41M |
| 3-Month Volatility | 28.86% | 20.46% |
| Beta | 0.43 | 0.89 |
Profitability
Return on Equity (TTM)
PFE
10.92%
Pharmaceuticals Industry
- Max
- 38.95%
- Q3
- 20.34%
- Median
- 11.59%
- Q1
- 3.32%
- Min
- -10.91%
PFE’s Return on Equity of 10.92% is on par with the norm for the Pharmaceuticals industry, indicating its profitability relative to shareholder equity is typical for the sector.
SYK
13.92%
Health Care Equipment & Supplies Industry
- Max
- 29.82%
- Q3
- 15.54%
- Median
- 9.69%
- Q1
- 5.19%
- Min
- -7.98%
SYK’s Return on Equity of 13.92% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
PFE
15.65%
Pharmaceuticals Industry
- Max
- 39.07%
- Q3
- 19.28%
- Median
- 13.48%
- Q1
- 5.73%
- Min
- -8.86%
PFE’s Net Profit Margin of 15.65% is aligned with the median group of its peers in the Pharmaceuticals industry. This indicates its ability to convert revenue into profit is typical for the sector.
SYK
12.07%
Health Care Equipment & Supplies Industry
- Max
- 24.65%
- Q3
- 14.10%
- Median
- 10.09%
- Q1
- 5.84%
- Min
- -6.13%
SYK’s Net Profit Margin of 12.07% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
PFE
16.52%
Pharmaceuticals Industry
- Max
- 45.58%
- Q3
- 24.35%
- Median
- 18.05%
- Q1
- 7.58%
- Min
- -11.88%
PFE’s Operating Profit Margin of 16.52% is around the midpoint for the Pharmaceuticals industry, indicating that its efficiency in managing core business operations is typical for the sector.
SYK
15.04%
Health Care Equipment & Supplies Industry
- Max
- 31.34%
- Q3
- 18.36%
- Median
- 15.07%
- Q1
- 9.62%
- Min
- -0.13%
SYK’s Operating Profit Margin of 15.04% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | PFE | SYK |
|---|---|---|
| Return on Equity (TTM) | 10.92% | 13.92% |
| Return on Assets (TTM) | 4.70% | 6.46% |
| Net Profit Margin (TTM) | 15.65% | 12.07% |
| Operating Profit Margin (TTM) | 16.52% | 15.04% |
| Gross Profit Margin (TTM) | 74.95% | 64.59% |
Financial Strength
Current Ratio (MRQ)
PFE
1.28
Pharmaceuticals Industry
- Max
- 5.45
- Q3
- 2.99
- Median
- 1.98
- Q1
- 1.29
- Min
- 0.78
PFE’s Current Ratio of 1.28 falls into the lower quartile for the Pharmaceuticals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
SYK
1.85
Health Care Equipment & Supplies Industry
- Max
- 4.97
- Q3
- 2.92
- Median
- 2.12
- Q1
- 1.54
- Min
- 0.86
SYK’s Current Ratio of 1.85 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
PFE
0.67
Pharmaceuticals Industry
- Max
- 1.79
- Q3
- 0.78
- Median
- 0.31
- Q1
- 0.08
- Min
- 0.00
PFE’s Debt-to-Equity Ratio of 0.67 is typical for the Pharmaceuticals industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
SYK
0.68
Health Care Equipment & Supplies Industry
- Max
- 1.62
- Q3
- 0.74
- Median
- 0.47
- Q1
- 0.15
- Min
- 0.00
SYK’s Debt-to-Equity Ratio of 0.68 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
PFE
7.89
Pharmaceuticals Industry
- Max
- 103.95
- Q3
- 43.60
- Median
- 10.15
- Q1
- 2.37
- Min
- -42.71
PFE’s Interest Coverage Ratio of 7.89 is positioned comfortably within the norm for the Pharmaceuticals industry, indicating a standard and healthy capacity to cover its interest payments.
SYK
14.59
Health Care Equipment & Supplies Industry
- Max
- 56.35
- Q3
- 24.86
- Median
- 9.84
- Q1
- 3.86
- Min
- -21.65
SYK’s Interest Coverage Ratio of 14.59 is positioned comfortably within the norm for the Health Care Equipment & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | PFE | SYK |
|---|---|---|
| Current Ratio (MRQ) | 1.28 | 1.85 |
| Quick Ratio (MRQ) | 0.97 | 0.94 |
| Debt-to-Equity Ratio (MRQ) | 0.67 | 0.68 |
| Interest Coverage Ratio (TTM) | 7.89 | 14.59 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
PFE
6.72%
Pharmaceuticals Industry
- Max
- 6.72%
- Q3
- 3.48%
- Median
- 1.90%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 6.72%, PFE offers a more attractive income stream than most of its peers in the Pharmaceuticals industry, signaling a strong commitment to shareholder returns.
SYK
0.92%
Health Care Equipment & Supplies Industry
- Max
- 4.36%
- Q3
- 1.87%
- Median
- 0.82%
- Q1
- 0.00%
- Min
- 0.00%
SYK’s Dividend Yield of 0.92% is consistent with its peers in the Health Care Equipment & Supplies industry, providing a dividend return that is standard for its sector.
Dividend Payout Ratio (TTM)
PFE
98.75%
Pharmaceuticals Industry
- Max
- 199.58%
- Q3
- 85.87%
- Median
- 49.36%
- Q1
- 1.12%
- Min
- 0.00%
PFE’s Dividend Payout Ratio of 98.75% is in the upper quartile for the Pharmaceuticals industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.
SYK
43.09%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 67.77%
- Median
- 28.21%
- Q1
- 0.00%
- Min
- 0.00%
SYK’s Dividend Payout Ratio of 43.09% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | PFE | SYK |
|---|---|---|
| Dividend Yield (TTM) | 6.72% | 0.92% |
| Dividend Payout Ratio (TTM) | 98.75% | 43.09% |
Valuation
Price-to-Earnings Ratio (TTM)
PFE
14.69
Pharmaceuticals Industry
- Max
- 52.64
- Q3
- 29.89
- Median
- 20.77
- Q1
- 13.37
- Min
- 5.71
PFE’s P/E Ratio of 14.69 is within the middle range for the Pharmaceuticals industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
SYK
46.83
Health Care Equipment & Supplies Industry
- Max
- 67.59
- Q3
- 41.41
- Median
- 33.11
- Q1
- 22.82
- Min
- 8.68
A P/E Ratio of 46.83 places SYK in the upper quartile for the Health Care Equipment & Supplies industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.
Price-to-Sales Ratio (TTM)
PFE
2.30
Pharmaceuticals Industry
- Max
- 8.74
- Q3
- 4.66
- Median
- 2.37
- Q1
- 1.67
- Min
- 0.11
PFE’s P/S Ratio of 2.30 aligns with the market consensus for the Pharmaceuticals industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
SYK
5.65
Health Care Equipment & Supplies Industry
- Max
- 9.49
- Q3
- 5.41
- Median
- 2.92
- Q1
- 1.97
- Min
- 0.61
SYK’s P/S Ratio of 5.65 is in the upper echelon for the Health Care Equipment & Supplies industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.
Price-to-Book Ratio (MRQ)
PFE
1.46
Pharmaceuticals Industry
- Max
- 9.86
- Q3
- 5.28
- Median
- 2.48
- Q1
- 1.57
- Min
- 0.59
PFE’s P/B Ratio of 1.46 is in the lower quartile for the Pharmaceuticals industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
SYK
6.49
Health Care Equipment & Supplies Industry
- Max
- 10.77
- Q3
- 6.04
- Median
- 3.32
- Q1
- 2.31
- Min
- 0.83
SYK’s P/B Ratio of 6.49 is in the upper tier for the Health Care Equipment & Supplies industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
Valuation at a Glance
| Symbol | PFE | SYK |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 14.69 | 46.83 |
| Price-to-Sales Ratio (TTM) | 2.30 | 5.65 |
| Price-to-Book Ratio (MRQ) | 1.46 | 6.49 |
| Price-to-Free Cash Flow Ratio (TTM) | 12.47 | 33.84 |